TrialFind
Saved trials
Back to results
Completed
Phase 3
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain
NCT00538850
What is this trial?
Generating plain-language summary...
Am I eligible?
Generating eligibility summary...
What's involved?
Summarizing study design...
Where and how to apply
Primary location
InSys Therapeutics, Incorporated
Chandler, Arizona, United States
View on ClinicalTrials.gov
Official details
Fentanyl Sublingual Spray in Treating Patients With Breakthrough Cancer Pain — TrialFind